Skip to content
Screener

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.53-47.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$19.55-954%
Danaher logo
DanaherDHR
$1.23+59.7%
OraSure Technologies logo
OraSure TechnologiesOSUR
$0.09+135%
Revvity logo
RevvityRVTY
$0.36+2.9%
Opko Health logo
Opko HealthOPK
-$0.01+94.7%

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$1.11B-30.1%
Enterprise value$4.42B-7.4%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0001906324-26-000033
Line itemThree Months Ended / June 28, 2026Three Months Ended / June 29, 2025Six Months Ended / June 28, 2026Six Months Ended / June 29, 2025
Other expense, net4.78.41.39.8
Loss before income taxes(81.2)(229.6)(160.7)(238.4)
Provision for income taxes11.725.824.029.7
Net loss$(92.9)$(255.4)$(184.7)$(268.1)
Basic loss per share$(1.36)$(3.77)$(2.71)$(3.97)
Diluted loss per share$(1.36)$(3.77)$(2.71)$(3.97)
Weighted-average shares outstanding - basic68.367.768.267.6
Weighted-average shares outstanding - diluted68.367.768.267.6

Item 1. Financial Statements (unaudited)

FAQ

What is QuidelOrtho Corporation's EPS (diluted)?
QuidelOrtho Corporation (QDEL) reported EPS (diluted) of -$1.36 in Q2 2026.
How has QuidelOrtho Corporation's EPS (diluted) changed year-over-year?
QuidelOrtho Corporation's EPS (diluted) increased by 63.9% year-over-year, from -$3.77 to -$1.36.
What is the long-term trend for QuidelOrtho Corporation's EPS (diluted)?
Over 2 years (2021 to 2025), QuidelOrtho Corporation's EPS (diluted) has grown at a 0.6% compound annual growth rate (CAGR), from $16.43 to -$16.64.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about QuidelOrtho Corporation's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude